戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 nome-and expressed HB surface antigen at levels relevant to patients.
2  with hypoxia and hemodynamic instability in critically ill patients.
3  detected in the BM plasma samples from MM compared to MGUS patients.
4 95% CI: 1.6, 2.3; P = .02); RB1 mutation (seen in 19 of 103 patients, 18.4%) was associated with peritoneal carcinomatosi
5                                    A total of 92 eyes of 47 patients (31 females) with mean age of 48.0 +/- 18.0 years an
6                            TP53 mutation (seen in 58 of 103 patients, 56%) was associated with lymphadenopathy (relative
7 ucture to measures of proximal and distal motor function in patients after hemispherotomy.
8 ctive for the treatment of anemia in chronic kidney disease patients and may also be beneficial for the treatment of dise
9 ent of rheumatoid arthritis (RA), a substantial minority of patients are exposed to multiple DMARDs without necessarily b
10 eism in nursing is particularly significant because it puts patients at risk by reducing the capacity of nurses to provid
11                               It included 205 eyes from 205 patients distributed in 82 normal corneas, 40 early-stage ker
12                                   Twenty-one studies (2'930 patients, five RCT, 16 observational studies) were retained f
13 the end of dasatinib induction therapy (day 85), 29% of the patients had a molecular response, and this percentage increa
14                                               Only 0.86% of patients had an HZ-related hospitalization.
15 ge acquisition method for capturing RBC images from the SCD patients in normoxia and hypoxia conditions.
16 llected between 20 February and 15 March 2020 from infected patients in Washington state in the United States.
17                                                 A subset of patients (n = 98) were selected for a WES-only pipeline if th
18 review was to investigate treatment outcomes among PWID and patients on OST in comparison to control cohorts.
19                         Outcomes were assessed according to patients' receipt of initial assessments by a lung cancer nur
20                              One hundred percent and 99% of patients received the assigned intervention in the PVI-alone
21                                                             Patients that undergo a TACE-treatment are categorised in par
22                                                   In the 12 patients, the coregistration of multimodal PET/MRI tumor data
23                                         Of 197 hospitalized patients, the mean (SD) age of the cohort was 60.6 (16.2) yea
24 duction in neuroinflammation by using samples from post-FMT patients to colonize GF mice shows a direct effect of fecal m
25 essive and usually noninvasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive an
26 ymphadenectomy leads to better disease-specific survival in patients treated with surgery alone.
27 es from gastrointestinal and blood cultures of 24 pediatric patients undergoing chemotherapy or hematopoietic stem cell t
28 MARDs without necessarily benefitting from them; a group of patients variously designated as having 'difficult to treat',
29             The mean age +/- standard deviation (SD) of the patients was 28.4 +/- 5.6 years (range: 18-43).
30 rst, 24 original articles containing of information of 3328 patients were evaluated.
31                                                    Thirteen patients were identified to have RRD within 3 months of intra
32                                                     216 066 patients were included.
33                                                       These patients were less likely to present Candida growth in all 3
34                                                             Patients were randomized 3:2 to suprachoroidally injected CLS
35                                              We compared 16 patients who had GHPs showing neoplastic transformation with
36 ents who had GHPs showing neoplastic transformation with 39 patients who had non-neoplastic GHPs.
37                                              A total of 151 patients who underwent a major hepatic resection were randomi
38  to 60% after two cycles of blinatumomab; the percentage of patients with a molecular response increased further after ad
39 A2 serotype (HLA-A2) that has been observed in about 35% of patients with acute myeloid leukaemia (AML).
40  remains underused in clinical practice, particularly among patients with alcohol-associated or NASH-related cirrhosis an
41 erence in the risk of cardiovascular death was observed for patients with and without postoperative AF (incidence rate, 4
42  score, 0 [interquartile range {IQR} 0-1] vs 1 [IQR 0-2] in patients with any positive BDG test; P = .039).
43                                     Information about where patients with limited health insurance receive maintenance di
44                                                          In patients with negative [TIMP-2]*[IGFBP7] at baseline, those w
45 ltraviolet B versus placebo and narrowband-ultraviolet B in patients with nonsegmental vitiligo.
46                             Improvements in the outcomes of patients with pancreatic ductal adenocarcinoma (PDAC) have la
47 ance has not yet been validated in a well-defined cohort of patients with PG.
48 The study was designed to detect improvement in outcomes of patients with stage II to IV DAWT compared with historical co
49 as single-agent therapy with a manageable safety profile in patients with treatment-naive, or relapse or refractory Walde
50                                                         For patients with ulcerative colitis, Eubacterium rectale and Akk